European Association of Urology
Guidelines
Education & Events
Join our events Join our events
On-demand education Learn at your own pace
Scholarships Enrich your capabilities
Exchange Programmes Urology beyond Europe
Education Educational Platforms Talent Incubator Programme Accreditation
Science & Publications
Publications Our publications
Research & Science Passionate about research?
About
Who we are Our mission and history
Our Board and Offices How we work
Join the EAU Find out about membership
Vacancies Contact

Special series: Artificial intelligence application for urologic cancer detection and classification

In 'Episode 4' of the special podcast series on "Uro-oncologic surgery driven by new technologies", Prof. Ricardo Autorino (IT) talks to expert Assoc. Prof. Giovanni Enrico Cacciamani (US) about Artificial intelligence application for urologic cancer detection and classification.

Published Sun, 8 Oct 2023
PodcastOncologyArtificial IntelligenceYAU Working Group Urotechnology Digital Health

Artificial Intelligence (AI) has revolutionised urologic cancer detection by leveraging principles from computer science, machine learning and deep learning. In this context, AI serves as a powerful tool to improve the accuracy and efficiency of cancer diagnosis and treatment.

Assoc. Prof. Cacciamani shares his knowledge how computer science forms the foundation of AI algorithms, enabling the processing and analysis of vast datasets, including medical images and patient records. Machine learning techniques, a subset of AI, are applied to these datasets to create predictive models that can identify patterns and anomalies within patient data. Deep learning, a specialised branch of machine learning, excels in image recognition tasks and has been instrumental in the interpretation of medical images like CT scans, MRI scans, and histopathological slides.

By implementing AI in urologic cancer detection, healthcare professionals can achieve faster and more accurate diagnosis, early cancer detection, and personalised treatment recommendations. AI systems can assist in the identification of tumours, tracking their growth over time, and predicting patient outcomes. This integration of AI technologies enhances the quality of patient care, potentially leading to better survival rates and improved overall well-being for individuals with urologic cancers.

This podcast was produced in collaboration with the YAU Urotechnology group. For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, Google Podcasts.

Contact our organiser

Email:  podcast@uroweb.org

Share this event

About EAU
  • Who we are
  • How we work
  • Become a member
Services
  • MyEAU
  • Congress registrations
  • Abstract submission
Media
  • EAU News
  • EAU Newsletter
  • EAU Press Releases
Contact
  • EAU Central Office
    PO Box 30016
    NL-6803 AA ARNHEM
    The Netherlands

  • Contact us
About EAU
Who we areHow we workBecome a member
Services
MyEAUCongress registrationsAbstract submission
Media
EAU NewsEAU NewsletterEAU Press Releases
Contact

EAU Central Office
PO Box 30016
NL-6803 AA ARNHEM
The Netherlands

Contact us
European Association of Urology
Privacy PolicyDisclaimer